Combined Diagnostic Efficacy of Liquid-Based Cytology and Hpv Testing in the Early Detection of Cervical Cancer

Cervical cancer screening liquid-based cytology human papillomavirus (HPV) co-testing cervical intraepithelial neoplasia (CIN) sensitivity

Authors

November 19, 2026

Downloads

Background: Cervical cancer (CC) remains one of the leading causes of cancer-related morbidity and mortality among women worldwide. Detection at the precancerous stage substantially improves treatment outcomes and survival. Objective: To evaluate the diagnostic sensitivity and specificity of liquid-based cytology (LBC) combined with high-risk human papillomavirus (hrHPV) testing (co-testing) compared with the conventional Papanicolaou (Pap) smear in detecting cervical precancerous lesions and early-stage cancer. Methods: In this prospective study, 240 women aged 25–60 years were randomized into two equal groups. Group I (n=120) underwent conventional Pap cytology; Group II (n=120) underwent LBC combined with PCR-based hrHPV testing. Final diagnoses were established by colposcopy and histopathological examination of directed biopsies. Results: The sensitivity of co-testing for CIN II+ lesions (moderate-to-severe dysplasia and worse) was 94.2%, versus 68.5% for the conventional Pap test (p<0.001). The false-negative rate was 4.5 times lower in Group II (4.1% vs 18.3%; p<0.001), and no LBC specimen was unsatisfactory, compared with 9.2% of conventional smears. Conclusion: Combining liquid-based cytology with hrHPV testing significantly improves the early diagnostic accuracy of cervical cancer screening and is a promising strategy for screening programs.